Table 6.
Summary of linear dose-response meta-analyses of prospective studies on yogurt intake and CVD, CHD, stroke, T2DM, and breast cancer.
| Authors, Year, Reference | No. of Studies | Each Increment Intake Per Day | RR (95% CI) | I2 Statistic | p-Value for Heterogeneity | Begg’s or Egger’s Test p-Value |
|---|---|---|---|---|---|---|
| Guo 2017 [33] | 3 | 50 g | CVD 1.03 (0.97–1.09) | 0.00% | 0.499 | NR |
| Guo 2017 [33] | 3 | 50 g | CHD 1.03 (0.97–1.09) | 0.00% | 0.685 | NR |
| de Goede 2016 [35] | 3 | 100 g | Stroke 1.02 (0.90–1.17) | 47.80% | 0.147 | NR |
| Aune 2013 [36] | 7 | 200 g | T2DM 0.78 (0.60–1.02) | 69.90% | 0.003 | 0.370 |
| Gao 2013 [37] | 7 | 50 g | T2DM incidence 0.91 (0.82–1.00) | 74.00% | 0.001 | NR |
| Gijsbers 2016 [38] | 12 | 50 g | T2DM incidence 0.94 (0.90–0.97) | 73.30% | 0.000 | 0.180 |
| Wu 2016 [41] | 3 | 200 g | Breast cancer incidence 0.87 (0.72–1.06) | 0.00% | NR | 1.000/0.488 |
CVD, cardiovascular disease; CHD, coronary heart disease; T2DM, type 2 diabetes mellitus; RR, relative risk; NR, not reported.